Marimed (MRMD) Accumulated Expenses (2012 - 2026)

Marimed (MRMD) has 14 years of Accumulated Expenses data on file, last reported at $10.4 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $10.4 million, up 34.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (up 34.0% YoY), and the FY2025 annual result was $9.5 million, up 114.41% from the prior year.
• Accumulated Expenses improved to $10.4 million in Q1 2026 per MRMD's latest filing, from $9.5 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $10.4 million in Q1 2026 and troughed at $1.7 million in Q1 2022.
• A 5-year average of $5.4 million and a median of $4.6 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses tumbled 70.57% in 2022, then jumped 114.41% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $3.1 million in 2022, then advanced by 14.82% to $3.5 million in 2023, then grew by 24.96% to $4.4 million in 2024, then jumped by 114.41% to $9.5 million in 2025, then rose by 8.92% to $10.4 million in 2026.
• Business Quant data shows MRMD's Accumulated Expenses at $10.4 million in Q1 2026, $9.5 million in Q4 2025, and $9.0 million in Q3 2025.